Practo eyes IPO next year after securing pre-IPO funding round. The healthtech startup is in advanced talks to raise between $100 million to $125 million in debt and equity, potentially valuing the company at $700 million pre-money. Backed by EBITDA profitability in FY25 and strong traction from its US pilot with over 200,000 doctors and $75 million GMV run rate, Practo is preparing for a public listing on Indian markets. The company is diversifying globally through its SaaS practice management software while expanding domestically via 40 cobranded dermatology clinics. Unlike previous IPO attempts, this push is anchored in fiscal discipline and sustainable margins, positioning Practo as a credible healthcare technology export story ready for capital markets scrutiny.
Post from MarketNews_en
Log in to interact with content.